addiction

First Opinion By Thomas McLellan and Jacob Crothers

Needed: an Operation Warp Speed for the opioid epidemic

Politics By Lev Facher

Biden administration will allow nearly all providers to prescribe buprenorphine

Health By Andrew Joseph

A new book traces the roots of the opioid crisis through the secretive Sackler family

First Opinion Podcast By Patrick Skerrett

Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters

First Opinion By Marvin D. Seppala

Money from opioid lawsuits is urgently needed now

First Opinion By Jeff Turiczek

Addiction and behavioral health care workers should have access to Covid-19 testing and vaccines

Health By Lev Facher

Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine

First Opinion By Eric McIntire

Peer recovery programs are an integral part of addiction treatment, recovery

First Opinion By Sean Fogler

As a physician and a patient, I’ve seen the damage caused by the stigma of addiction. It must end

First Opinion By Richard Bottner, Christopher Moriates, and Matthew Stefanko

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

Health By Alice Proujansky

Pregnancy poses challenges for people in recovery from substance use disorder. Covid-19 is taxing their support system

Health Tech By Erin Brodwin

Nearly a year since opening its doors, here’s how Verily’s addiction medicine campus is taking shape

Politics By Amy Sokolow

Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets 

Pharmalot By Ed Silverman

A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial

First Opinion By David A. Patterson Silver Wolf

Real-time data are essential for Covid-19. They’re just as important for the opioid overdose crisis

Health By Lev Facher

Covid-19 has streamlined addiction medicine. Will the changes stick?

Pharmalot By Ed Silverman

Despite evidence, many primary care doctors don’t want to prescribe medications for addiction

Health By Alison Insinger

Methadone clinic lines and packed waiting rooms leave clients vulnerable to the coronavirus

First Opinion By Miriam Komaromy and Michael Botticelli

A radical approach to preventing Covid-19 infection in the homeless

First Opinion By Haider J. Warraich

What an 1890s opioid epidemic can teach us about ending addiction today

Business By Andrew Joseph

Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?

First Opinion By Lila Flavin and J. Wesley Boyd

A government database is supposed to help people seeking treatment for opioid addiction. It often doesn’t

Health By Andrew Joseph and Shraddha Chakradhar

Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

Health Tech By Casey Ross

Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders

First Opinion By William Stauffer

Addiction treatment is broken. Here’s what it should look like